These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 22200843)

  • 1. bFGF peptide combined with the pVAX-8CpG plasmid as adjuvant is a novel anticancer vaccine inducing effective immune responses against Lewis lung carcinoma.
    Li M; Shi HS; Zhang HL; Luo ZC; Wan Y; Lu L; Luo ST; Yang L
    Mol Med Rep; 2012 Mar; 5(3):625-30. PubMed ID: 22200843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the protective effects of truncated bFGF and native bFGF against murine lung carcinoma.
    Luo Z; Peng X; Shi H; Gong C; Qian Z; Yang L
    Int J Mol Med; 2011 Jul; 28(1):3-8. PubMed ID: 21503566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel combined conjugate vaccine: enhanced immunogenicity of bFGF with CRM197 as a carrier protein.
    Zhang HL; Yuan C; Zhang DM; Shi HS; Li M; Luo ZC; Wan Y; Lu L; Luo ST; Yang L
    Mol Med Rep; 2011; 4(5):857-63. PubMed ID: 21720718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An N-, C-terminally truncated basic fibroblast growth factor and LPD (liposome-polycation-DNA) complexes elicits a protective immune response against murine colon carcinoma.
    Zhang XP; Yang L; Shi HS; Zhao X; Deng HX; Xiao WJ; Mao YQ; Kan B; Liu YL; Zhang S; Li ZM; Zhang J; Wei YQ
    Cancer Biol Ther; 2010 Aug; 10(3):276-81. PubMed ID: 20543584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel liposomal vaccine improves humoral immunity and prevents tumor pulmonary metastasis in mice.
    Zhong Z; Wei X; Qi B; Xiao W; Yang L; Wei Y; Chen L
    Int J Pharm; 2010 Oct; 399(1-2):156-62. PubMed ID: 20692327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy of tumor with vaccine based on basic fibroblast growth factor-activated fibroblasts.
    Li X; Wang Y; Zhao Y; Yang H; Tong A; Zhao C; Shi H; Li Y; Wang Z; Wei Y
    J Cancer Res Clin Oncol; 2014 Feb; 140(2):271-80. PubMed ID: 24322179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel vaccine adjuvant LPS-Hydrogel for truncated basic fibroblast growth factor to induce antitumor immunity.
    Shi HS; Gong CY; Zhang HL; Wang YS; Zhang J; Luo ZC; Qian ZY; Wei YQ; Yang L
    Carbohydr Polym; 2012 Aug; 89(4):1101-9. PubMed ID: 24750920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The novel complex combination of alum, CpG ODN and HH2 as adjuvant in cancer vaccine effectively suppresses tumor growth in vivo.
    Tian Y; Li M; Yu C; Zhang R; Zhang X; Huang R; Lu L; Yuan F; Fan Y; Zhou B; Men K; Xu H; Yang L
    Oncotarget; 2017 Jul; 8(28):45951-45964. PubMed ID: 28515346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble production and function of vascular endothelial growth factor/basic fibroblast growth factor complex peptide.
    Zhang Q; Lao X; Huang J; Zhu Z; Pang L; Tang Y; Song Q; Huang J; Deng J; Deng N; Yang Q; Sengupta AM; Xiong L
    Biotechnol Prog; 2015; 31(1):194-203. PubMed ID: 25271020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer vaccines: single-epitope anti-idiotype vaccine versus multiple-epitope antigen vaccine.
    Maruyama H; Zaloudik J; Li W; Sperlagh M; Koido T; Somasundaram R; Scheck S; Prewett M; Herlyn D
    Cancer Immunol Immunother; 2000 Jun; 49(3):123-32. PubMed ID: 10881691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Particle-size-dependent toxicity and immunogenic activity of mesoporous silica-based adjuvants for tumor immunotherapy.
    Wang X; Li X; Ito A; Sogo Y; Ohno T
    Acta Biomater; 2013 Jul; 9(7):7480-9. PubMed ID: 23541601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-delivery of doxorubicin and plasmid by a novel FGFR-mediated cationic liposome.
    Xiao W; Chen X; Yang L; Mao Y; Wei Y; Chen L
    Int J Pharm; 2010 Jun; 393(1-2):119-26. PubMed ID: 20416367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(I:C)/alum mixed adjuvant priming enhances HBV subunit vaccine-induced immunity in mice when combined with recombinant adenoviral-based HBV vaccine boosting.
    Chuai X; Chen H; Wang W; Deng Y; Wen B; Ruan L; Tan W
    PLoS One; 2013; 8(1):e54126. PubMed ID: 23335993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel vaccine delivery system: biodegradable nanoparticles in thermosensitive hydrogel.
    Wu QJ; Zhu XC; Xiao X; Wang P; Xiong da K; Gong CY; Wang YS; Yang L; Wei YQ
    Growth Factors; 2011 Dec; 29(6):290-7. PubMed ID: 21981422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody responses to crucial functional epitopes as a novel approach to assess immunogenicity of vaccine adjuvants.
    Awasthi S; Hook LM; Swaminathan G; Cairns TM; Brooks B; Smith JS; Ditto NT; Gindy ME; Bett AJ; Espeseth AS; Cohen GH; Friedman HM
    Vaccine; 2019 Jun; 37(29):3770-3778. PubMed ID: 31153687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A vaccine targeting basic fibroblast growth factor elicits a protective immune response against murine melanoma.
    Zhang X; Li NL; Guo C; Li YD; Luo LL; Liu YQ; Duan YY; Li ZD; Xie XR; Song HX; Yang LP; An FY
    Cancer Biol Ther; 2018 Jun; 19(6):518-524. PubMed ID: 29405828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The swine CD81 enhances E2-based DNA vaccination against classical swine fever.
    Li W; Mao L; Zhou B; Liu X; Yang L; Zhang W; Jiang J
    Vaccine; 2015 Jul; 33(30):3542-8. PubMed ID: 26051512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single and combination herpes simplex virus type 2 glycoprotein vaccines adjuvanted with CpG oligodeoxynucleotides or monophosphoryl lipid A exhibit differential immunity that is not correlated to protection in animal models.
    Khodai T; Chappell D; Christy C; Cockle P; Eyles J; Hammond D; Gore K; McCluskie MJ; Evans DM; Lang S; Loudon PT; Townend T; Wright P; West K; Bright H
    Clin Vaccine Immunol; 2011 Oct; 18(10):1702-9. PubMed ID: 21852545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial surface display of endoglin by antigen 43 induces antitumor effectiveness via bypassing immunotolerance and inhibition of angiogenesis.
    Huang FY; Li L; Liu Q; Li YN; Bai RZ; Huang YH; Zhao HG; Guo JL; Zhou SL; Wang H; Lin YY; Tan GH
    Int J Cancer; 2014 Apr; 134(8):1981-90. PubMed ID: 24150860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alum Adjuvant and Built-in TLR7 Agonist Synergistically Enhance Anti-MUC1 Immune Responses for Cancer Vaccine.
    Zhou SH; Li YT; Zhang RY; Liu YL; You ZW; Bian MM; Wen Y; Wang J; Du JJ; Guo J
    Front Immunol; 2022; 13():857779. PubMed ID: 35371101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.